No Data
Changhua Chemical: First Quarter Report for 2026
Changhua Chemical: 2025 Annual Report
Changhua Chemical: Summary of the 2025 Annual Report
Changhua Chemical (301518.SZ): Trial production of the carbon dioxide polyether and high-performance polyol project (Phase I, Stage 1)
Changhua Chemical (301518.SZ) announced that its wholly-owned subsidiary, Changhua Chemical Technology (Lianyungang) Co., Ltd. (referred to as “Changhua Lianyungang”), recently received the expert panel’s opinion on the trial production plan for the first phase of the new carbon dioxide polyether and high-performance polyol project issued jointly by the Lianyungang Emergency Management Bureau and the Xuyuan New District Emergency Management Bureau. The expert panel confirmed that the facility is ready for trial production. The scope of this trial production includes: an 80,000-ton-per-year carbon dioxide polyether unit, a 200,000-ton-per-year polyether polyol production unit, a 700-ton-per-year catalyst unit, and supporting facilities.
Express News | Changhua Chemical: Its wholly-owned subsidiary, Changhua Lianyungang, has received the expert group's opinion on the trial production plan.
Priced 20% higher but still in high demand, has the logic changed? Who is entering A-share private placements at high premiums? Which industries are commanding such high premiums?
①Since the beginning of the year, a batch of private placement projects with a premium rate exceeding 20% has been successfully issued; ②The private placement market has abandoned the primitive 'discount-only theory'; ③Various capital forces, including public and private funds, insurance funds, brokerages, industrial capital, and several prominent individual investors, have all actively participated in high-premium private placement projects.